CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-10-05 | Doberstein Stephen K SVP & Chief Scientific Officer | Exercise or conversion · Stock Option | −43,677 | 396,323 | ||
| 2017-10-02 | Labrucherie Gil M SVP & Chief Financial Officer | Exercise or conversion | +120,000 | $11.34 | $1.4M | 183,414 |
| 2017-10-02 | Labrucherie Gil M SVP & Chief Financial Officer | Sale | −120,000 | $24.45 | $2.9M | 63,414 |
| 2017-10-02 | Labrucherie Gil M SVP & Chief Financial Officer | Exercise or conversion · Stock Option | −120,000 | 0 | ||
| 2017-10-02 | Gergel Ivan P. SVP & Chief Medical Officer | Exercise or conversion | +56,704 | $11.04 | $626K | 98,279 |
| 2017-10-02 | Gergel Ivan P. SVP & Chief Medical Officer | Sale | −56,704 | $24.21 | $1.4M | 41,575 |
| 2017-10-02 | Gergel Ivan P. SVP & Chief Medical Officer | Exercise or conversion · Stock Option | −56,704 | 313,752 | ||
| 2017-09-29 | Gergel Ivan P. SVP & Chief Medical Officer | Exercise or conversion | +43,296 | $11.04 | $478K | 84,871 |
| 2017-09-29 | Gergel Ivan P. SVP & Chief Medical Officer | Sale | −43,296 | $24.04 | $1.0M | 41,575 |
| 2017-09-29 | Gergel Ivan P. SVP & Chief Medical Officer | Exercise or conversion · Stock Option | −43,296 | 370,456 | ||
| 2017-09-22 | Lingnau Lutz Director | Sale | −5,000 | $21.97 | $110K | 27,450 |
| 2017-09-22 | KUEBLER CHRISTOPHER A Director | Sale | −4,000 | $21.86 | $87K | 40,500 |
| 2017-09-21 | CHESS ROBERT Director | Sale | −6,400 | $21.72 | $139K | 274,223 |
| 2017-09-19 | Ajer Jeffrey Robert Director | Grant or award | +13,500 | 13,500 | ||
| 2017-09-19 | Ajer Jeffrey Robert Director | Grant or award | +9,000 | 22,500 | ||
| 2017-09-19 | Ajer Jeffrey Robert Director | Grant or award · Stock Option | +33,750 | 33,750 | ||
| 2017-09-19 | Ajer Jeffrey Robert Director | Grant or award · Stock Option | +22,500 | 22,500 | ||
| 2017-09-19 | WINGER DENNIS L Director | Grant or award | +9,000 | 43,250 | ||
| 2017-09-19 | WINGER DENNIS L Director | Grant or award · Stock Option | +22,500 | 22,500 | ||
| 2017-09-19 | KUEBLER CHRISTOPHER A Director | Grant or award | +9,000 | 44,500 |
Page 40 of 43 · 847 trades